| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.54B | 77.02B | 80.65B | 80.42B | 78.72B | 74.08B |
| Gross Profit | 27.07B | 26.82B | 26.70B | 24.47B | 22.90B | 22.51B |
| EBITDA | 9.30B | 9.78B | 8.67B | 8.75B | 7.86B | 9.17B |
| Net Income | 4.12B | 4.38B | 3.73B | 3.12B | 2.63B | 3.80B |
Balance Sheet | ||||||
| Total Assets | 55.95B | 54.96B | 53.15B | 53.15B | 58.45B | 60.31B |
| Cash, Cash Equivalents and Short-Term Investments | 13.08B | 13.64B | 9.69B | 11.40B | 14.03B | 16.56B |
| Total Debt | 15.25B | 15.24B | 13.52B | 14.06B | 17.92B | 14.02B |
| Total Liabilities | 39.88B | 36.46B | 35.53B | 35.93B | 41.63B | 37.90B |
| Stockholders Equity | 12.78B | 14.99B | 14.23B | 13.89B | 13.37B | 18.66B |
Cash Flow | ||||||
| Free Cash Flow | 4.65B | 5.09B | 4.66B | 1.85B | 1.24B | 2.42B |
| Operating Cash Flow | 7.87B | 8.20B | 8.26B | 5.49B | 4.48B | 5.42B |
| Investing Cash Flow | -2.91B | -5.31B | -2.86B | -3.72B | -3.38B | -4.04B |
| Financing Cash Flow | -4.01B | -2.38B | -4.67B | -7.32B | -4.62B | -6.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$22.83B | 8.93 | 19.70% | 4.49% | 15.34% | 30.46% | |
69 Neutral | HK$7.56B | 26.14 | 8.86% | 1.41% | 4.96% | 64.85% | |
67 Neutral | HK$52.52B | 8.37 | 23.50% | 3.26% | 2.03% | 1.43% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | HK$68.15B | ― | 24.09% | 5.46% | -1.95% | 20.50% | |
59 Neutral | HK$66.93B | -26.78 | 3.79% | 3.62% | -7.24% | 1390.75% | |
58 Neutral | HK$6.44B | 13.00 | 7.63% | 2.21% | -3.39% | 91.63% |